Venom Bumble Bee (Bombus terrestrus) IgE
Use
The Venom Bumble Bee IgE test is intended for the quantitative determination of IgE antibodies to the venom of the Bumble Bee (Bombus terrestrus) in serum. This test helps in assessing allergic sensitivity to the bumble bee venom, assisting clinicians in diagnosing venom allergies and aiding in the management of allergic reactions caused by bumble bee stings.
Special Instructions
Not provided.
Limitations
The test has not been cleared or approved by the FDA and its performance characteristics were determined by Eurofins Viracor. The test results should not be used as the sole basis for a diagnosis; they must be interpreted considering the patient's clinical status and other diagnostic tests. Hemolysis, lipemia, and icterus can lead to specimen rejection, impacting the availability of results. As a non-FDA cleared test, it should be used in conjunction with other diagnostic procedures.
New York Approved
Methodology
Immunoassay (FEIA)
Biomarkers
Venom Bumble Bee IgE
Protein
LOINC Codes
- 6056-6 - Bumble Bee IgE Qn
- 6056-6 - Bumble Bee IgE Qn
- 102196-3 - Bumble Bee IgE RAST
Result Turnaround Time
3-6 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.5 mL
Container
Red Top
Collection Instructions
Draw blood in a plain red-top tube(s), serum gel tube(s) is acceptable. Spin down and send 0.5 mL of serum refrigerated in a plastic vial.
Storage Instructions
Refrigerate the serum sample, preferably.
Causes for Rejection
Hemolysis, Lipemia, Icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 28 days |
| Refrigerated | 28 days |
| Frozen | 365 days |